A profile of the cobas® CT/NG assay on the cobas® 6800/8800 system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae

Expert Rev Mol Diagn. 2020 Apr;20(4):375-380. doi: 10.1080/14737159.2020.1724093. Epub 2020 Feb 3.

Abstract

Introduction: Chlamydia trachomatis and Neisseria gonorrhoeae infection rates continue to rise worldwide. Increasing screening of the largely asymptomatic infections is critical for timely and effective disease control. Laboratory solutions that can handle increasing volumes and generate highly accurate test results are needed in reference labs that provide the majority of chlamydia/gonorrhea testing.Areas covered: This review will describe the Roche cobas CT/NG assay performed on the cobas 6800/8800 system. The instrument features will be described as will the performance of the assay.Expert opinion: The high throughput cobas 6800/8800 can be integrated with clinical chemistry, hematology and immunology systems which will increase reference lab efficiency. The broad menu, ease of expansion with lab developed tests, in combination with features that support lab efficiencies and cost management while assuring high sensitivity and specificity, make this a uniquely effective diagnostic tool.

Keywords: Chlamydia trachomatis; Neisseria gonorrhoeae; laboratory diagnostics; molecular diagnostics; sexually transmitted infections.

MeSH terms

  • Chlamydia Infections / diagnosis*
  • Chlamydia Infections / microbiology
  • Chlamydia trachomatis* / genetics
  • Gonorrhea / diagnosis*
  • Gonorrhea / microbiology
  • High-Throughput Screening Assays*
  • Humans
  • Molecular Diagnostic Techniques
  • Neisseria gonorrhoeae* / genetics
  • Nucleic Acid Amplification Techniques / economics
  • Nucleic Acid Amplification Techniques / methods*
  • Nucleic Acid Amplification Techniques / standards
  • Reagent Kits, Diagnostic*
  • Sensitivity and Specificity

Substances

  • Reagent Kits, Diagnostic